COMPARISON OF HIGH-DOSE EBRT AND EBRT WITH BRACHYTHERAPY BOOST IN TREATMENT OF PROSTATE CANCER PATIENTS

被引：0
|
作者：
Smolska-Ciszewska, B. [1 ]
Miszczyk, L. [2 ]
Bialas, B. [3 ]
Gawkowska-Suwinska, M. [1 ]
Plewicki, G. [1 ]
Fijalkowski, M. [3 ]
Giglok, M. [1 ]
Behrendt, K. [1 ]
Nowicka, E. [1 ]
Zajusz, A. [1 ]
机构：
[1] Marie Sklodowska Curie Mem Canc Ctr & Inst Oncol, Gliwice Branch, Radiotherapy Clin 2, Gliwice, Poland
[2] Marie Sklodowska Curie Mem Canc Ctr & Inst Oncol, Gliwice Branch, Dept Radiotherapy, Gliwice, Poland
[3] Marie Sklodowska Curie Mem Canc Ctr & Inst Oncol, Gliwice Branch, Dept Brachytherapy, Gliwice, Poland
来源：
RADIOTHERAPY AND ONCOLOGY | 2010年 / 96卷
关键词：
D O I：
暂无
中图分类号：
R73 [肿瘤学];
学科分类号：
100214 ;
摘要：
1181
引用
收藏
页码：S398 / S398
页数：1
相关论文
共 50 条
  • [31] 10-year results in 1577 intermediate/high risk prostate cancer patients treated with external beam RT (EBRT) and hypofractionated high dose rate (HDR) brachytherapy boost
    Ghilezan, M.
    Galalae, R.
    Demanes, J.
    Schour, L.
    Gustafson, G.
    Nuemberg, N.
    Wallace, M.
    Martinez, A.
    [J]. INTERNATIONAL JOURNAL OF RADIATION ONCOLOGY BIOLOGY PHYSICS, 2007, 69 (03): : S83 - S84
  • [32] HIGH-DOSE-RATE BRACHYTHERAPY (HDR-BT) COMBINED WITH EXTERNAL BEAM RADIATION THERAPY (EBRT) IN PATIENTS WITH PROSTATE CANCER
    Inomata, T.
    Shimbo, T.
    Takahashi, M.
    Uesugi, Y.
    Azuma, H.
    Katsuoka, Y.
    [J]. RADIOTHERAPY AND ONCOLOGY, 2008, 88 : S327 - S327
  • [33] Quality of Life, Treatment Toxicity, and Biochemical Control in Patients Treated with Dose-Escalation Brachytherapy and EBRT for Intermediate- and High-Risk Prostate Cancer
    Pierson, C.
    Saxena, S.
    Kelly, S.
    Ju, A. W.
    Chen, R. C.
    [J]. INTERNATIONAL JOURNAL OF RADIATION ONCOLOGY BIOLOGY PHYSICS, 2019, 105 (01): : E596 - E596
  • [34] Long Term Follow-up of Patients Receiving High Dose Rate (HDR) Brachytherapy Boost in Combination with External Beam Radiotherapy Treatment (EBRT) for High Risk Prostate Cancer: Relapse Rate and Toxicity
    Swampillai, A.
    Lewis, R.
    Payne, H.
    [J]. CLINICAL ONCOLOGY, 2009, 21 (10) : 801 - 801
  • [35] Propensity score-matched analysis comparing prostate EBRT versus EBRT plus HDR brachytherapy
    Tamihardja, J.
    Lawrenz, I.
    Lutyj, P.
    Kraft, J.
    Zimmermann, M.
    Weick, S.
    Flentje, M.
    Polat, B.
    [J]. RADIOTHERAPY AND ONCOLOGY, 2022, 170 : S478 - S479
  • [36] Early toxicity outcomes: A single 15Gy fraction HDR brachytherapy as pre-treatment EBRT boost in prostate cancer
    Chicas Sett, R.
    Soler, A.
    Fernandez, J.
    Burgos, J.
    Pons, O.
    Roldan, S.
    Celada, F.
    Gimeno, J.
    Tormo, A.
    Perez-Calatayud, J.
    [J]. RADIOTHERAPY AND ONCOLOGY, 2015, 115 : S357 - S357
  • [37] Early toxicity outcomes: A single 15Gy fraction HDR brachytherapy as pre-treatment EBRT boost in prostate cancer
    Chicas Sett, R.
    Soler, A.
    Fernandez, J.
    Burgos, J.
    Pons, O.
    Roldan, S.
    Celada, F.
    Gimeno, J.
    Tormo, A.
    Perez-Calatayud, J.
    [J]. RADIOTHERAPY AND ONCOLOGY, 2015, 115 : V - V
  • [38] High dose rate brachytherapy as a boost for the treatment of localized prostate cancer
    Phan, Thinh P.
    Syed, A. M. Nisar
    Puthawala, Ajmel
    Sharma, Anil
    Khan, Farhan
    [J]. JOURNAL OF UROLOGY, 2007, 177 (01): : 123 - 127
  • [39] Hypoxia and angiogenic biomarkers in prostate cancer after external beam radiotherapy (EBRT) alone or combined with high-dose-rate brachytherapy boost (HDR-BTb)
    Bhattacharya, Indrani S.
    Sharabiani, Mansour Taghavi Azar
    Alonzi, Roberto
    Hoskin, Peter J.
    [J]. RADIOTHERAPY AND ONCOLOGY, 2019, 137 : 38 - 44
  • [40] Late sequelae in 400 prostate cancer patients treated with combined EBRT and HDR-brachytherapy
    Boehmer, D
    Deger, S
    Dinges, S
    Loening, SA
    Budach, V
    [J]. PROGRESS IN RADIO-ONCOLOGY VII, PROCEEDINGS, 2001, : 731 - 732
12345